Activation of FoxO1 prevents and reverses cardiac hypertrophy from diverse stimuli

Area of Science:

• Cardiology
• Molecular Biology
• Physiology

Background:

• The heart undergoes structural and functional remodeling in response to various stimuli.
• Cardiac hypertrophy, a thickening of the heart muscle, is well-studied at the molecular level.
• Mechanisms driving the regression of cardiac hypertrophy after stimulus removal are less understood.

Purpose of the Study:

• To investigate the molecular mechanisms underlying cardiac hypertrophy regression.
• To identify key proteins and pathways involved in reversing cardiac enlargement.
• To explore the role of forkhead box proteins (FoxOs) in cardiac mass regulation.

Main Methods:

• Studied cardiac hypertrophy regression in mouse models following exercise and pregnancy.
• Analyzed the expression and activation of forkhead box proteins (FoxOs).
• Investigated the impact of FoxO1 activation on adrenergic agonist-induced pathological hypertrophy.

Main Results:

• Activation of forkhead box proteins (FoxOs) and increased expression of their autophagy targets are common in cardiac hypertrophy regression.
• Exercise and pregnancy in mice are associated with FoxO activation during hypertrophy regression.
• FoxO1 activation was sufficient to prevent and reverse pathological cardiac hypertrophy induced by adrenergic agonists.

Conclusions:

• Forkhead box proteins (FoxOs), particularly FoxO1, play a crucial role in the regression of cardiac hypertrophy.
• FoxO1 activation is a key regulator of cardiac mass and can counteract pathological cardiac remodeling.
• Understanding FoxO-mediated pathways offers potential therapeutic targets for managing cardiac hypertrophy.